What is Rydapt used to treat?
Medically reviewed by Drugs.com Last updated on Jun 25, 2019.
Official Answerby Drugs.com
Rydapt (midostaurin) from Novartis Pharmaceuticals is an oral, multi-targeted kinase inhibitor approved to treat acute myeloid leukemia (AML). Rydapt is for patients who have been newly-diagnosed with an FMS-like tyrosine kinase-3 (FLT3) mutation, and can be used to treat advanced systemic mastocytosis (SM), which includes aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated hematological neoplasm (SM-AHN) and mast cell leukemia.
Related Medical Questions
- How does Venclexta work?
- What is Idhifa used to treat?
- What is Tibsovo used to treat?
- What type of cancer is Daurismo (glasdegib) used to treat?
- What type of leukemia is Xospata (gilteritinib) used to treat?
- Rydapt Information for Consumers
- Rydapt Information for Healthcare Professionals (includes dosage details)
- Side Effects of Rydapt (detailed)